Cencora, Inc.
$327.60
+3.25 · +1.00% today
Market open · updated 12:44:26 PM ET
- High
- $328.00 7:35 AM
- Low
- $322.50 4:45 AM
Against the S&P 500 Price change through Oct 27, 2026
COR−3.67%
S&P 500+12.87%
COR−3.18%
S&P 500+12.32%
COR+73.40%
S&P 500+87.41%
COR+172.16%
S&P 500+69.55%
Key numbers
- Previous close
- $324.35
- Open
- $328.84
- Day's range
- $326.34 – $329.55
- 52-week range
- $244.82 – $377.54
- Volume
- 288,998
- Average volume
- 1.4 million
- Market value
- $62.5 billion
- Price to earnings
- 24.4last 12 months
- Earnings per share
- $13.59last 12 months
- Beta
- 0.58moves less than the market
- Dividend
- $2.40 a year · 0.73%
- 50-day average
- $322.79
- 200-day average
- $317.26
Wednesday, Nov 4, 2026, before the open.
Analyst price targets and the full financials are in the terminal.
Who Cencora buys from, sells to and competes with From our value chain
Cencora in the news
No desk stories on COR yet. When we write about it, the story leads this list.
- HeadlineCencora (COR) Reports Next Week: Wall Street Expects Earnings GrowthZacks Investment Research · October 28, 2026 at 11:01 AM ET
- HeadlineCencora to Acquire AON in $2.4B Deal to Expand Oncology NetworkZacks Investment Research · October 28, 2026 at 10:41 AM ET
- HeadlineCencora to acquire American Oncology Network in $2.4 billion dealReuters · October 21, 2026 at 7:38 AM ET
- HeadlineCencora to Acquire American Oncology Network to Strengthen Support of Community OncologyBusiness Wire · October 21, 2026 at 7:30 AM ET
- CongressRo Khanna bought $1,001 - $15,000 of CORHouse filing · disclosed Oct 9, 2026
- CongressJared Moskowitz sold $1,001 - $15,000 of CORHouse filing · disclosed Jun 22, 2026
- CongressJared Moskowitz bought $1,001 - $15,000 of CORHouse filing · disclosed May 1, 2026
- CongressJared Moskowitz bought $1,001 - $15,000 of CORHouse filing · disclosed May 1, 2026
Earnings
Next report: Wednesday, Nov 4, 2026, before the open.
Congress trades in COR
4 purchases and 3 sales in the latest 7 filings.
| Member | Trade | Amount | Traded | Disclosed |
|---|---|---|---|---|
| Ro KhannaHouse · D-California | Purchase | $1,001 - $15,000 | Sep 4, 2026 | Oct 9, 2026 |
| Jared MoskowitzHouse · D-Florida | Sale | $1,001 - $15,000 | May 6, 2026 | Jun 22, 2026 |
| Jared MoskowitzHouse · D-Florida | Purchase | $1,001 - $15,000 | Mar 31, 2026 | May 1, 2026 |
| Jared MoskowitzHouse · D-Florida | Purchase | $1,001 - $15,000 | Mar 23, 2026 | May 1, 2026 |
| Jefferson ShreveHouse · R-Indiana | Sale | $50,001 - $100,000 | May 12, 2025 | Jun 23, 2025 |
| Greg LandsmanHouse · D-Ohio | Sale | $15,001 - $50,000 | Mar 27, 2025 | Apr 9, 2025 |
| Ro KhannaHouse · D-California | Purchase | $1,001 - $15,000 | Nov 15, 2024 | Dec 6, 2024 |
Source: Periodic transaction reports filed with the House and the Senate · Members disclose ranges, not exact amounts, and may file weeks after the trade.
About Cencora
Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Employees
- 49,000
- Headquarters
- Conshohocken, Pennsylvania
- Website
- cencora.com
- Listed
- Apr 4, 1995
More medical - distribution stocks
The price refreshes every 15 seconds while the market is open and carries the time it was read. Company figures are updated each evening. Built from WiseView and market data and public filings. For information only, not investment advice.